Panbela Therapeutics Stock Fundamentals
Panbela Therapeutics fundamentals help investors to digest information that contributes to Panbela Therapeutics' financial success or failures. It also enables traders to predict the movement of Panbela Stock. The fundamental analysis module provides a way to measure Panbela Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Panbela Therapeutics stock.
Panbela |
Panbela Therapeutics Company Return On Equity Analysis
Panbela Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Panbela Therapeutics Return On Equity | -7.98 |
Most of Panbela Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Panbela Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Panbela Therapeutics has a Return On Equity of -7.9816. This is 66.7% lower than that of the Biotechnology sector and 78.11% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Panbela Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Panbela Therapeutics's current stock value. Our valuation model uses many indicators to compare Panbela Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Panbela Therapeutics competition to find correlations between indicators driving Panbela Therapeutics's intrinsic value. More Info.Panbela Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Panbela Therapeutics' earnings, one of the primary drivers of an investment's value.Panbela Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Panbela Therapeutics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Panbela Therapeutics could also be used in its relative valuation, which is a method of valuing Panbela Therapeutics by comparing valuation metrics of similar companies.Panbela Therapeutics is currently under evaluation in return on equity category among its peers.
Panbela Fundamentals
| Return On Equity | -7.98 | ||||
| Return On Asset | -1.92 | ||||
| Current Valuation | 8.64 M | ||||
| Shares Outstanding | 3.48 M | ||||
| Shares Owned By Institutions | 0.59 % | ||||
| Number Of Shares Shorted | 106.97 K | ||||
| Price To Book | 3.22 X | ||||
| EBITDA | (34.76 M) | ||||
| Net Income | (34.93 M) | ||||
| Cash And Equivalents | 2.53 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 6.84 M | ||||
| Current Ratio | 0.56 X | ||||
| Book Value Per Share | (16.57) X | ||||
| Cash Flow From Operations | (15.28 M) | ||||
| Short Ratio | 0.07 X | ||||
| Earnings Per Share | (157.02) X | ||||
| Target Price | 410.0 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 3.93 M | ||||
| Total Asset | 4.98 M | ||||
| Retained Earnings | (91.09 M) | ||||
| Working Capital | (6.06 M) | ||||
| Z Score | -49.78 | ||||
| Net Asset | 4.98 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Panbela Stock
If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |